Achieve Life Sciences (ACHV) Other Operating Expenses (2010 - 2026)

Achieve Life Sciences' (ACHV) quarterly Other Operating Expenses came in at $341000.0 in Q1 2026, up 610.42% on a QoQ basis from $48000.0 in Q4 2025.

Achieve Life Sciences (ACHV) Other Operating Expenses (2010 - 2026) Analysis & Trends

Achieve Life Sciences (ACHV) has 7 years of Other Operating Expenses data on file, last reported at $341000.0 in Q1 2026.

Quarterly Other Operating Expenses changed N/A year-over-year to $341000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $389000.0 (changed N/A YoY) and the FY2025 annual result came in at $48000.0, changed N/A from the prior year.
Other Operating Expenses grew to $341000.0 in Q1 2026, from $48000.0 in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $341000.0 in Q1 2026 to a low of $48000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Achieve Life Sciences	330.88 Mn	330.88 Mn	-

Download Data